Listen "S13.E5: My Life On GLP1 - Mounjaro & Fatty Liver Disease: Groundbreaking Research"
Episode Synopsis
74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans with fatty liver disease. From friend Jerry's diagnosis story to clinical trial data, learn why this GLP-1 medication could transform liver treatment forever.
#FattyLiver #LiverDisease #Mounjaro #MASH #GLP1
https://mylifeonglp1.com/fatty-liver-disease/
https://mylifeonglp1.com/
#FattyLiver #LiverDisease #Mounjaro #MASH #GLP1
https://mylifeonglp1.com/fatty-liver-disease/
https://mylifeonglp1.com/
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.